Novel opiate reduction utilizing catalytic hydrogen transfer reaction

Details for Australian Patent Application No. 2008241528 (hide)

Owner Mallinckrodt Inc.

Inventors Cantrell, Gary L.; Berberich, David Wayne; Wang, Peter X.; Jiang, Tao

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008241528

PCT Pub. Number WO2008/130553

Priority 60/911,950 16.04.07 US

Filing date 15 April 2008

Wipo publication date 30 October 2008

International Classifications

C07D 489/02 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

C07D 489/08 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/130553 Priority application(s): WO2008/130553

3 November 2011 Assignment before Grant

  Mallinckrodt Inc. The application has been assigned to Mallinckrodt LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008241532-Macrocyclic ghrelin receptor modulators and methods of using the same

2008241527-Triazole derivatives which are Smo antagonists